Unknown PHASE2 INTERVENTIONAL 2-arm NCT03040180

Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer (nECT)

Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer: a Randomized Clinical Phase II Trial

Sponsor: Herlev Hospital

Conditions Down Staging Electrochemotherapy Locally Advanced Rectal Cancer Neoadjuvant Therapy

Interventions Electrochemotherapy with bleomycin EndoVE

Updated 7 times since 2017 Last updated: Jan 24, 2019 Started: Jan 31, 2017 Primary completion: Jun 30, 2019 Completion: Sep 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Down Staging and Electrochemotherapy, this trial is ongoing. The trial is conducted by Herlev Hospital and has accumulated 7 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Feb 2021 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2021 [monthly]

Recruiting PHASE2
Feb 2019 — Jan 2021 [monthly]

Recruiting PHASE2

▶ Show 2 earlier versions

Jun 2018 — Feb 2019 [monthly]

Recruiting PHASE2
Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Herlev Hospital
Rigshospitalet, Denmark
Zealand University Hospital

Data source: Zealand University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Herlev, Denmark
• Roskilde, Denmark